1 (587) 885 3158 clinic@magiccalgary.ca


PAtient ExpeRIence in Fabry Disease On VenglustaT


A randomized, double-blind, placebo-controlled, 12-month Phase III study to evaluate the effect of Venglustat on neuropathic and abdominal pain in male and female adults with Fabry disease who are treatment-naive or untreated for at least 6 months. (Click the image to see more information)